Use Code ELEVATE10 for 10% off any subscription. View Products

Weekly Elevate Watchlist 10/10/21

Weekly Elevate Watchlist 10/10/21

Hey everyone, hope everyone is having a great weekend. About to start my sunday watchlist. Bare with me, this will be a larger watchlist, since there is quite a few new developments, news coming, BTC hit 56550… So like i said alot happened over the weekend. Let’s get to it.

Let’s start with what to eye tomorrow.

$DATS, alot of hype there, this was a runner at the end of september. After the dip, shorts are stacked in here hard. We’re seeing a lot of volume to squeeze these shorts out. Here’s the chart to eye here.
With $DATS going strong, make sure to eye the sympathy $PALT. Here’s the chart to eye on this one, these wedges take, look for a big move.
$BTC, broke a key trend last week. Here’s some resistance areas to eye as we keep moving up. WIth $BTC moving. Make sure to always have a eye on the block chain plays, $BTBT, $MARA, $RIOT, $NCTY, $CAN, $BITF, $HUT are a few that come to the top on my head. as you know, i have a few of these as swings. and will continue hold as BTC moves higher

On a side note about $BTC, there was this headline to keep a eye on throughout the week. 

Stocks with news over the weekend,
$TRVI, Pursuant to Rule 477 promulgated under the Securities Act of 1933 (the “Securities Act”), Trevi Therapeutics, Inc. (the “Company”) hereby applies for the immediate withdrawal of the above-referenced Registration Statement, which was originally filed with the Securities and Exchange Commission (the “Commission”) on August 27, 2021, together with all exhibits thereto. The Registration Statement was filed in connection with the proposed public offering by the Company of its common stock, par value $0.001 per share, which the Company has determined not to pursue at this time. The Registration Statement has not been declared effective by the Commission. The Company confirms that it has not sold any securities pursuant to the Registration Statement. This daily is really really beat up as well. have a close eye on this tomorrow for sure.
$RGNX, REGENXBIO Presents Positive Initial Data from Phase II ALTITUDE™ Trial of RGX-314 for the Treatment of Diabetic Retinopathy Using Suprachoroidal Delivery at American Society of Retina Specialists Annual Meeting. 8% short on the float. Have a eye on it as well tomorrow.
$AVDM, Adverum Presents Clinical Data ADVM-022 at the American Society of Retina Specialists 39th Annual Scientific Meeting. on Monday, October 11, 2021 at 8:50 am CT (9:50 am ET). have a eye on this during this call as well. that will be right after the bell.

You think that was a lot, there is a TON of news coming for certain stocks. Let’s go through them so you know what stocks have catalyst coming just like our swing last week $CCXI.

$OCGN, Should know if were going to get approval on the covaxin vaccine their partnered with. Alerted already, news should be out soon this week. Here’s a link to the WHO’s twitter saying that it should be this week. Here’s the chart im eyeing as well. if all goes well, Ill look for that top trend as a PT.
$AVDL, Announces FDA Acceptance of New Drug Application for FT218 in Adults with Narcolepsy for the Treatment of Excessive Daytime Sleepiness and Cataplexy, target action date of October 15, 2021. News will be out on friday. Here’s the symmetrical triangle to eye here. Here’s a link to the news coming. 
$MNKD and $UTHR, MannKind and United Therapeutics Achieve a Major Milestone in the Development of Tyvaso DPI™ With New Drug Application Acceptance From the FDA. which is expected to be complete in October 2021. Im seeing this will be out on the 15th as well. Here’s the link to the news coming, as well as a chart to eye.
$OMER, There is a ton of news here. I’ll go through it in pieces.
On the 17th(next saturday) they have a date with the FDA for biologics License Application for Narsoplimab in the Treatment of HSCT-TMA.
On october 1st this news came out.
Omeros Corporation (Nasdaq: OMER) today announced that the U.S. Food and Drug Administration (FDA) notified the company that, as part of FDA’s ongoing review of the company’s Biologics License Application (BLA) for narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), FDA has identified deficiencies that preclude discussion of labeling and post-marketing requirements/commitments at this time. FDA stated that the notification does not reflect a final decision on the information under review.
This daily is in the slaughter house. JPM called downgraded them to overweight as well. like i said a TON of news. There’s some DD on them. heres the beat up chart as well.
$OYST, Oyster Point Pharma Announces FDA Acceptance for Filing New Drug Application for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye Disease with a target day of October 17, 2021, here’s the link to the news coming as well as its chart, and its pretty beat up too.
Last but not least, $OCUL. Ocular Therapeutix™ Announces FDA Acceptance of Supplemental New Drug Application for DEXTENZA® (dexamethasone ophthalmic insert) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis The FDA has set an action date under the Prescription Drug User Fee Act (PDUFA) of no later than October 18, 2021. Here’s the link to the news. Here’s another beat up chart as well.
Wow, like i said a TON of news coming with the FDA, vaccines, all sorts of fun things coming in the next few weeks. Excited for that!

Let’s talk about some highly shorted/oversold stocks that have potential to squeeze.

$RGS, 21% short on the float here, stock is in the dirt. I mean it’s a total slaughterhouse, not going to try and catch the falling knife, but Ill be look for volume to show for a day trade. Have an eye on it.
$FBRX is in the slaughter house as well, on sept 2nd the headline was Clinical Trial of FB-401 For the Treatment of Atopic Dermatitis Fails to Meet Statistical Significance. Lots of downgrades. 21% is short on the float. Shorts getting greedy. Eye it
$OTRK, a ton of insider selling here, i mean a ton. Just smashed down, 32% short on the float. I’ll be eyeing for a short squeeze here in the coming weeks. Would be good to see some insider buying soon.

I could keep going, others to eye as well that are oversold/highly shorted, SKLZ 20% short, WKHS, 39% short, CLOV 14% short, APPH, 25% short

Here’s the highest shorted stocks in the markets.

Thanks for reading, Hell of a list today, lots of work, but well worth. With all this news coming, tons of highly shorted stocks. I think its going to be a great week! 

Amazing Week for the team,  Don’t miss another monster move, Elevate your trading today by signing up today at Use promo code ELEVATE10 for 10% off all packages and join the best team out there! 🔥 💰



The forum, blog, watchlist and chatrooms on the Site are comprised of customers and members (including, without limitation, moderators who are in the employ of Elevate Trader) posting content and information. All such information and content is for informational purposes only and does not constitute advice or a recommendation by Elevate Trader to enter into any securities transactions or engage in any of the financial strategies reflected on or suggested in forum, blog, watchlist and chatrooms (whether such data, content or information is posted by Elevate Trader or otherwise). Customers and members may write about securities in which they have a financial or other interest, and performance data reflecting other customer’s or member’s holdings may include information about securities not held by Elevate Trader or its directors, officers, shareholders, employees, agents or affiliates. As such, Elevate Trader is not responsible for the accuracy of data, content or information or any performance data in any forum, blog, watchlist and chatrooms; and the accuracy of data, content or information or any performance data are not guaranteed, may not be current and should not be relied upon. Nothing in any forum, blog, watchlist and chatrooms is intended as, nor should you rely on it as, investment advice provided by Elevate Trader or its directors, officers, shareholders, employees, agents or affiliates.


Try a trial – for less than a cup of coffee